Ilina, Yulia
Kaufmann, Paul
Melander, Olle
Press, Michaela
Thuene, Katrin
Bergmann, Andreas
Funding for this research was provided by:
European Regional Development Fund (80256636)
Federal State of Brandenburg
Article History
Received: 16 May 2023
Accepted: 30 June 2023
First Online: 4 July 2023
Competing interests
: Y.I, P.K, M.P, K.T. are employed by PAM Theragnostics GmbH, A.B. has shares in and is managing director of PAM Theragnostics GmbH, the company holding patent rights for PAM-LIA assay. O.M. declares to have neither disclosures nor financial or non-financial competing interests.